SecBot SecBot
6-K ·Filed Apr 1, 2026

GLAXF

GSK plc
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001654954-26-003122
Notable filing: 6-K
Actionable Insight • Neutral

This routine share buyback is unlikely to significantly impact the stock price. Monitor the 20-F annual report (filed March 6, 2026) for fundamental performance indicators that would provide more meaningful trading signals than this mechanical buyback activity.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
GLAXF ▼ -2.76% at T+60d
NEUTRAL call -2.76% · α vs SPY -16.14% · entry $26.05 → $25.33
Entry = T+0 close
Apr 1, 2026
via day close
T+1d
+2.69%
call +2.69% · α +2.61%
$26.75
settled 7mo ago
T+5d
+7.60%
call +7.60% · α +3.84%
$28.03
settled 7mo ago
T+20d
+3.95%
call +3.95% · α -5.77%
$27.08
settled 6mo ago
T+60d
-2.76%
call -2.76% · α -16.14%
$25.33
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

GSK plc purchased 340,000 of its ordinary shares on March 31, 2026, at an average price of 2,075.26 GBp per share, as part of its ongoing buyback program. Since February 17, 2026, the company has bought back 16.22 million shares. This transaction increases the company's treasury shares to 256.1 million, representing 6.31% of voting rights.

Key Facts

  • GSK purchased 340,000 ordinary shares on March 31, 2026
  • Average price paid was 2,075.26 GBp per share
  • Total treasury shares now stand at 256,112,615 (6.31% of voting rights)
  • Part of existing buyback program announced on February 17, 2026
  • Since program inception, 16,221,521 shares have been purchased

Financial Impact

The company spent approximately £7.06 million (340,000 shares × 2,075.26 GBp) on this repurchase

share counttreasury stockdilution

Risk Factors

  • Limited immediate market impact from routine buyback activity
  • Potential for misinterpretation as a bullish signal when it's merely execution of a pre-announced program

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-003122
Document: 0001654954-26-003122-index-headers.html0001654954-26-003122
Document: 0001654954-26-003122-index.html0001654954-26-003122
Document: 0001654954-26-003122.txt0001654954-26-003122
51 reports for GLAXF
Performance horizon
46% Hit rate @ T+5 6 of 13 directional calls Went positive at some point 7 of 13 best @ T+20▲ +9.49%Jun 9, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
TypeNow
Jun 10, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$25.12 $25.25▲ +0.52%▼ −1.62%$26.12 (+3.98%)
Jun 9, 2026
20w ago
6-K
NEUTRAL ★ 1/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 9, 2026
20w ago
6-K
BULLISH ★ 7/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
May 28, 2026
21w ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.12 (+6.27%)
May 27, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.12 (+2.15%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 22, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.12 (+0.46%)
Showing 10 of 51

US Market Status

Market Closed — Opens Wed (15h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026